Results 61 to 70 of about 785,080 (295)

Seventeenth report / Expert Committee on Specifications for Pharmaceutical Preparations

, 1960
"The Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 9-14 November 1959"WHO/Pharm/37733 ...
World Health Organization, World Health Organization. Expert Committee on Specifications for Pharmaceutical Preparations   +1 more
core  

Twentieth report / Expert Committee on Specifications for Pharmaceutical Preparations

, 1963
"This session of the Expert Committee on Specifications for Pharmaceutical Preparations was held in Geneva from 19 to 23 November 1962"14, 13 ...
World Health Organization, World Health Organization. Expert Committee on Specifications for Pharmaceutical Preparations   +1 more
core  

Comité de Expertos de la OMS en Especificaciones para las Preparaciones Farmacéuticas [se reunió en Ginebra del 3 al 9 de noviembre de 1964] : 21o informe [PDF]

, 1965
35 ...
World Health Organization, WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting   +1 more
core  

Choroid Plexus Enlargement and USPIO‐Based Inflammatory Feature in Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choroid plexus (CP) is a key component of the blood–cerebrospinal fluid barrier (BCSFB), but its mechanism of action in cerebral small vessel disease (CSVD) remains unclear. This study investigated CP volume (CPV) alterations and their association with conventional imaging markers in CSVD and explored the underlying role of ...
Yongqiang Qu, Xiaoning Ren, Cuihua Fan, Chun Li, Lijie Zhang, Zaiqiang Zhang, Shaowu Li, Zhongmeng Lai, Bin Cai, Ying Fu, Yi Lin, Zhibao Zhu   +11 more
wiley   +1 more source

Twenty-third report / Expert Committee on Specifications for Pharmaceutical Preparations

, 1969
"The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 25 to 29 November 1969"WHO/PHARM/70.45613 ...
World Health Organization, World Health Organization. Expert Committee on Specifications for Pharmaceutical Preparations   +1 more
core  

Pharmaceutical preparations, except biologicals : 2004 [PDF]

, 2005
Current industrial report.

core  

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative   +24 more
wiley   +1 more source

Pharmaceutical preparations, except biologicals : 1999 [PDF]

, 2000
Current industrial report.

core  

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz   +19 more
wiley   +1 more source

Chalasoergodimers A–E, heterodimers with multiple polymerization modes from a marine-derived Chaetomium sp. fungus

Natural Products and Bioprospecting
Five new heterodimers, chalasoergodimers A–E (1–5), and three known heterodimers (6–8), along with four chaetoglobosin monomers (9–12), were isolated from a marine-derived Chaetomium sp. fungus.
Ze-Hong Lin, Han-Wen Shan, Li-Kun Yang, Tian-Tian Sun, Li-Ying He, Hui-Fang Du, Ya-Hui Zhang, Shan Liu, Xu Wang, Du-Qiang Luo, Fei Cao   +10 more
doaj   +1 more source